These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 4078360)

  • 21. Patients with erythema nodosum leprosum lack T-suppressor cells.
    Wallach D; Flageul B; Cottenot F; Bach MA
    Arch Dermatol; 1985 Nov; 121(11):1379. PubMed ID: 2932061
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
    Sharma VK; Saha K; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythema nodosum leprosum in a case of histoid leprosy.
    Kaur S; Dhar S; Sharma VK; Ray R
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):292-3. PubMed ID: 8371037
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy.
    Shannon EJ; Miranda RO; Morales MJ; Hastings RC
    Scand J Immunol; 1981; 13(6):553-62. PubMed ID: 7031850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
    Miller RA; Shen JY; Rea TH; Harnisch JP
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyethylene glycol precipitates in serum during and after erythema nodosum leprosum--study of their composition and anticomplementary activity.
    Saha K; Chakrabarty AK; Sharma VK; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):44-8. PubMed ID: 6538557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
    Sehgal VN; Sharma V; Sharma VK
    Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
    Valentijn RM; Faber WR; Lai A Fat RF; Chan Pin Jie JC; Daha MR; van Es LA
    Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
    [No Abstract]   [Full Text] [Related]  

  • 29. Ultrastructure of nerve in erythema nodosum leprosum (ENL).
    Anthony J; Vaidya MC; Dasgupta A
    Cytobios; 1979; 26(102):109-12. PubMed ID: 550966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
    Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
    Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histoid leprosy with histoid leproma in peripheral nerves--a case report.
    Rajan MA; Palande DD
    Indian J Lepr; 1985; 57(2):389-92. PubMed ID: 3001196
    [No Abstract]   [Full Text] [Related]  

  • 32. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythema nodosum leprosum in borderline leprosy. Report of a case.
    Karat AB; Job CK; Karat S
    Int J Lepr Other Mycobact Dis; 1967; 35(1):17-24. PubMed ID: 6067034
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards understanding the pathology of erythema nodosum leprosum.
    Kahawita IP; Lockwood DN
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):329-37. PubMed ID: 18313706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type II (ENL) reaction in histoid leprosy in a child.
    Sehgal VN; Chaudary AK; Mahajan DM; Bedi BS
    Lepr Rev; 1991 Dec; 62(4):431-2. PubMed ID: 1784159
    [No Abstract]   [Full Text] [Related]  

  • 37. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS; Glovsky M
    Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histoid leprosy with ENL reaction.
    Sharma SK; Rath N; Gautam RK; Sharma PK; Jain RK; Kar HK
    Indian J Dermatol Venereol Leprol; 2002; 68(6):342-3. PubMed ID: 17656995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythema nodosum leprosum and orbital involvement.
    Dhaliwal U; Mohanty S; Bhattacharya SN
    Int J Lepr Other Mycobact Dis; 2003 Mar; 71(1):10-3. PubMed ID: 12914128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.